Normal CSF neuron-specific enolase and S-100 protein levels in patients with recent non-complicated tonic-clonic seizures

被引:42
作者
Palmio, J
Peltola, J
Vuorinen, P
Laine, S
Suhonen, J
Keränen, T
机构
[1] Tampere Univ Hosp, Dept Neurol, FIN-33521 Tampere, Finland
[2] Tampere Univ Hosp, Dept Clin Microbiol, FIN-33521 Tampere, Finland
[3] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland
[4] Cent Hosp, Dept Neurol, Jyvaskyla, Finland
关键词
neuron-specific enolase; S-100; protein; cerebrospinal fluid; epilepsy;
D O I
10.1016/S0022-510X(00)00478-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: Increased concentrations of the nervous-system-specific proteins neuron-specific enolase (NSE) and S-100 protein (S-100) have been measured with lesions in the CNS. Elevated levels of serum NSE (s-NSE) have been found in status epilepticus, but also after single epileptic seizures. Because larger studies addressing cerebrospinal fluid (CSF) levels of NSE or S-100 have not been performed, we measured CSF NSE and S-100 after tonic-clonic seizures to search for evidence of neuronal and glial damage. Methods: 22 consecutive patients with single, previously undiagnosed and untreated tonic-clonic seizures were studied. Serum and CSF samples were collected within 24 h after seizure. 18 serum and CSF samples were measured from a control group. Results: The mean CSF NSE was 8.9 ng/ml (range 0-28 ng/ml) and s-NSE 8.2 ng/ml (range 5-15 ng/ml) in the patient group. The mean concentrations in the control group were 13.1 ng/ml (range 3-24 ng/ml) and 8.0 ng/ml (range 5-12 ng/ml) respectively. The mean CSF S-100 was 3.17 mug/l (range 1.45-7.02 mug/l) and serum S-100 0.05 mug/l(range 0-0.32 mug/l), and in controls 3.19 mug/l (range 1.52-5.13 mug/l) and 0.08 mug/l (range 0-0.28 mug/l). Conclusion: There were no significant differences between the mean concentrations of NSE or S-100 in CSF and serum between the epileptic group and controls. These results do not confirm the previous observation of elevated NSE-levels after tonic-clonic seizures, which argues against neuronal or glial damage after uncomplicated tonic-clonic seizures in unmedicated patients. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:27 / 31
页数:5
相关论文
共 19 条
[1]   PROPOSAL FOR REVISED CLINICAL AND ELECTROENCEPHALOGRAPHIC CLASSIFICATION OF EPILEPTIC SEIZURES [J].
BANCAUD, J ;
HENRIKSEN, O ;
RUBIODONNADIEU, F ;
SEINO, M ;
DREIFUSS, FE ;
PENRY, JK .
EPILEPSIA, 1981, 22 (04) :489-501
[2]   S-100 protein: Serum marker of focal brain damage after ischemic territorial MCA infarction [J].
Buttner, T ;
Weyers, S ;
Postert, T ;
Sprengelmeyer, R ;
Kuhn, W .
STROKE, 1997, 28 (10) :1961-1965
[3]   Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier [J].
Correale, J ;
Rabinowicz, AL ;
Heck, CN ;
Smith, TD ;
Loskota, WJ ;
DeGiorgio, CM .
NEUROLOGY, 1998, 50 (05) :1388-1391
[4]   SERUM NEURON-SPECIFIC ENOLASE IN HUMAN STATUS EPILEPTICUS [J].
DEGIORGIO, CM ;
CORREALE, JD ;
GOTT, PS ;
GINSBURG, DL ;
BRACHT, KA ;
SMITH, T ;
BOUTROS, R ;
LOSKOTA, WJ ;
RABINOWICZ, AL .
NEUROLOGY, 1995, 45 (06) :1134-1137
[5]   Neuron-specific enolase, a marker of acute neuronal injury, is increased in complex partial status epilepticus [J].
DeGiorgio, CM ;
Gott, PS ;
Rabinowicz, AL ;
Heck, CN ;
Smith, TD ;
Correale, JD .
EPILEPSIA, 1996, 37 (07) :606-609
[6]   Serum neuron-specific enolase in the major subtypes of status epilepticus [J].
DeGiorgio, CM ;
Heck, CN ;
Rabinowicz, AL ;
Gott, PS ;
Smith, T ;
Correale, J .
NEUROLOGY, 1999, 52 (04) :746-749
[7]  
KO F-J, 1990, Kaohsiung Journal of Medical Sciences, V6, P137
[8]   S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke [J].
Missler, U ;
Wiesmann, M ;
Friedrich, C ;
Kaps, M .
STROKE, 1997, 28 (10) :1956-1960
[9]  
OTTO M, 1998, EPILEPSIA S2, V39, P73
[10]   S-100 PROTEIN AND NEURON-SPECIFIC ENOLASE IN CEREBROSPINAL-FLUID AND SERUM - MARKERS OF CELL-DAMAGE IN HUMAN CENTRAL-NERVOUS-SYSTEM [J].
PERSSON, L ;
HARDEMARK, HG ;
GUSTAFSSON, J ;
RUNDSTROM, G ;
MENDELHARTVIG, I ;
ESSCHER, T ;
PAHLMAN, S .
STROKE, 1987, 18 (05) :911-918